Comments
Loading...

Q32 Bio

QTTBNASDAQ
Logo brought to you by Benzinga Data
$24.55
-2.49-9.21%
At close: -
$24.55
00.00%
After Hours: Nov 22, 4:20 PM EDT
Consensus Rating1
Outperform
Highest Price Target1
$100.00
Lowest Price Target1
$45.00
Consensus Price Target1
$72.33

Q32 Bio (NASDAQ:QTTB) Stock, Analyst Ratings, Price Targets, Forecasts

Q32 Bio Inc has a consensus price target of $72.33 based on the ratings of 6 analysts. The high is $100 issued by Guggenheim on June 17, 2024. The low is $45 issued by Piper Sandler on April 2, 2024. The 3 most-recent analyst ratings were released by Raymond James, Wells Fargo, and Guggenheim on October 24, 2024, September 11, 2024, and June 17, 2024, respectively. With an average price target of $95 between Raymond James, Wells Fargo, and Guggenheim, there's an implied 286.97% upside for Q32 Bio Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jun
1
Sep
1
Oct
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.6
Strong Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Raymond James
Wells Fargo
Guggenheim
Leerink Partners
Oppenheimer

1calculated from analyst ratings

Analyst Ratings for Q32 Bio

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Q32 Bio (QTTB) stock?

A

The latest price target for Q32 Bio (NASDAQ:QTTB) was reported by Raymond James on October 24, 2024. The analyst firm set a price target for $90.00 expecting QTTB to rise to within 12 months (a possible 266.60% upside). 6 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Q32 Bio (QTTB)?

A

The latest analyst rating for Q32 Bio (NASDAQ:QTTB) was provided by Raymond James, and Q32 Bio initiated their strong buy rating.

Q

When was the last upgrade for Q32 Bio (QTTB)?

A

There is no last upgrade for Q32 Bio

Q

When was the last downgrade for Q32 Bio (QTTB)?

A

There is no last downgrade for Q32 Bio.

Q

When is the next analyst rating going to be posted or updated for Q32 Bio (QTTB)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Q32 Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Q32 Bio was filed on October 24, 2024 so you should expect the next rating to be made available sometime around October 24, 2025.

Q

Is the Analyst Rating Q32 Bio (QTTB) correct?

A

While ratings are subjective and will change, the latest Q32 Bio (QTTB) rating was a initiated with a price target of $0.00 to $90.00. The current price Q32 Bio (QTTB) is trading at is $24.55, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch